Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

The business combination reinforces Crown’s position as a leading, innovative, high-growth aesthetics and skincare company JOHNSON CITY, Tenn., Feb. 6, 2025 /PRNewswire/ — Crown Laboratories, Inc. (“Crown”), a privately held, global innovative leader in the skincare industry, today…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.